Terms: = Endocrine gland cancer AND MYD88, Q99836, MYD88D, 4615
75 results:
1. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
Zhang W; Yang P; Yang Y; Liu S; Xu Y; Wu C; Wang J; Liu C; Liu H; Li S; Huang W; Jing H
J Transl Med; 2024 May; 22(1):414. PubMed ID: 38693538
[TBL] [Abstract] [Full Text] [Related]
2. "Quadruple-hit" primary testicular diffuse large B-cell lymphoma with myd88 L265P mutation, IGH::MYC, and IRF4- and BCL6-rearrangements.
Bruehl FK; Ketterling RP; Rimsza LM; Santos EF; McPhail ED
J Hematop; 2023 Sep; 16(3):161-165. PubMed ID: 38175404
[TBL] [Abstract] [Full Text] [Related]
3. P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer.
Bates M; Mullen D; Lee E; Costigan D; Heron EA; Kernan N; Barry-O'Crowley J; Martin C; Keegan H; Malone V; Brooks RD; Brooks DA; Logan JM; Martini C; Selemidis S; McFadden J; O'Riain C; Spillane CD; Gallagher MF; McCann A; O'Toole S; O'Leary JJ
Pathol Res Pract; 2024 Jan; 253():155020. PubMed ID: 38103365
[TBL] [Abstract] [Full Text] [Related]
4. Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis.
Zhu Z; Yi B; Tang Z; Chen X; Li M; Xu T; Zhao Z; Tang C
BMC Cancer; 2023 Oct; 23(1):1044. PubMed ID: 37904102
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
[No Abstract] [Full Text] [Related]
6. Cytologic, histologic, and molecular features of pancreatic sarcomatoid undifferentiated carcinoma with heterologous osteosarcomatous transformation.
Zhang ML; Sabatino ME; Castillo CF; Mattia AR; Chebib I
Diagn Cytopathol; 2023 May; 51(5):E164-E169. PubMed ID: 36762822
[TBL] [Abstract] [Full Text] [Related]
7. PAUF Induces Migration of Human Pancreatic cancer Cells Exclusively via the TLR4/myd88/NF-κB Signaling Pathway.
Youn SE; Jiang F; Won HY; Hong DE; Kang TH; Park YY; Koh SS
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232715
[TBL] [Abstract] [Full Text] [Related]
8. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the myd88-dependent NF-κB signaling pathway.
Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
[TBL] [Abstract] [Full Text] [Related]
9. [Expression of lnc-myd88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
[No Abstract] [Full Text] [Related]
10. Preoperative assessment of cervical lymph node metastases in patients with papillary thyroid carcinoma: Incremental diagnostic value of dual-energy CT combined with ultrasound.
Yoon J; Choi Y; Jang J; Shin NY; Ahn KJ; Kim BS
PLoS One; 2021; 16(12):e0261233. PubMed ID: 34898649
[TBL] [Abstract] [Full Text] [Related]
11. Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/myd88/AKT/NF-κB pathway in pancreatic cancer.
Yin H; Pu N; Chen Q; Zhang J; Zhao G; Xu X; Wang D; Kuang T; Jin D; Lou W; Wu W
Cell Death Dis; 2021 Oct; 12(11):1033. PubMed ID: 34718325
[TBL] [Abstract] [Full Text] [Related]
12. The role of the MAD2-TLR4-myd88 axis in paclitaxel resistance in ovarian cancer.
Bates M; Spillane CD; Gallagher MF; McCann A; Martin C; Blackshields G; Keegan H; Gubbins L; Brooks R; Brooks D; Selemidis S; O'Toole S; O'Leary JJ
PLoS One; 2020; 15(12):e0243715. PubMed ID: 33370338
[TBL] [Abstract] [Full Text] [Related]
13. The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers.
Lupi LA; Cucielo MS; Silveira HS; Gaiotte LB; Cesário RC; Seiva FRF; de Almeida Chuffa LG
Life Sci; 2020 Apr; 247():117435. PubMed ID: 32081661
[TBL] [Abstract] [Full Text] [Related]
14. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.
King RL; Goodlad JR; Calaminici M; Dotlic S; Montes-Moreno S; Oschlies I; Ponzoni M; Traverse-Glehen A; Ott G; Ferry JA
Virchows Arch; 2020 May; 476(5):647-665. PubMed ID: 31863183
[TBL] [Abstract] [Full Text] [Related]
15. P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian cancer SKOV-3 Cells: A Preliminary Study.
Lupi LA; Delella FK; Cucielo MS; Romagnoli GG; Kaneno R; Nunes IDS; Domeniconi RF; Martinez M; Martinez FE; Fávaro WJ; Chuffa LGA
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861351
[TBL] [Abstract] [Full Text] [Related]
16. Morphologic Patterns and the Correlation With myd88 L265P, CD79B Mutations in Primary Adrenal Diffuse Large B-Cell Lymphoma.
Chen Z; Zou Y; Liu W; Guan P; Tao Q; Xiang C; Zhang W; Ye Y; Yan J; Zhao S
Am J Surg Pathol; 2020 Apr; 44(4):444-455. PubMed ID: 31609782
[TBL] [Abstract] [Full Text] [Related]
17. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian cancer.
Baert T; Vankerckhoven A; Riva M; Van Hoylandt A; Thirion G; Holger G; Mathivet T; Vergote I; Coosemans A
Front Immunol; 2019; 10():1273. PubMed ID: 31214202
[TBL] [Abstract] [Full Text] [Related]
18. TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition.
Zandi Z; Kashani B; Poursani EM; Bashash D; Kabuli M; Momeny M; Mousavi-Pak SH; Sheikhsaran F; Alimoghaddam K; Mousavi SA; Ghaffari SH
Eur J Pharmacol; 2019 Jun; 853():256-263. PubMed ID: 30930249
[TBL] [Abstract] [Full Text] [Related]
19. Extracellular S100A11 Plays a Critical Role in Spread of the Fibroblast Population in Pancreatic cancers.
Takamatsu H; Yamamoto KI; Tomonobu N; Murata H; Inoue Y; Yamauchi A; Sumardika IW; Chen Y; Kinoshita R; Yamamura M; Fujiwara H; Mitsui Y; Araki K; Futami J; Saito K; Iioka H; Ruma IMW; Putranto EW; Nishibori M; Kondo E; Yamamoto Y; Toyooka S; Sakaguchi M
Oncol Res; 2019 Jun; 27(6):713-727. PubMed ID: 30850029
[TBL] [Abstract] [Full Text] [Related]
20. [Association of Body Mass Index and Risk Stratification of Thyroid Nodules in a Multi-center Healthy Population].
Wang Y; Lai XJ; Yang X; Deng XW; Jiang SQ; Yang XW; Tang SQ; Wang J; Ma CM; Li L; Zhang B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Feb; 41(1):93-98. PubMed ID: 30837049
[TBL] [Abstract] [Full Text] [Related]
[Next]
